Surgical Glue Market Size, Share, Growth, and Industry Analysis, By Type (Cyanoacrylate, Fibrin Sealant, Collagen-Based Compound, Glutaraldehyde Glue, Hydrogel, Others), By Application (Hospitals, Clinics), Regional Insights and Forecast to 2034

Surgical Glue Market Overview

The Surgical Glue Market size was valued at USD 4020.88 million in 2025 and is expected to reach USD 6210.99 million by 2034, growing at a CAGR of 4.6% from 2025 to 2034.

The Surgical Glue Market expanded significantly during 2025 because hospitals increasingly adopted tissue adhesives for wound closure, cardiovascular procedures, and minimally invasive surgeries. More than 329 million surgical procedures were performed globally during 2025, while approximately 41% of surgeons preferred surgical glue products for selected soft tissue closure applications. Fibrin sealants accounted for nearly 32% of global surgical adhesive demand because they improved hemostasis efficiency and reduced operating time by approximately 18%. Surgical Glue Market Analysis indicates that cyanoacrylate-based products represented approximately 29% of total product consumption during 2025 due to fast polymerization and strong bonding performance in emergency and outpatient procedures.

The United States Surgical Glue Market remained one of the most advanced globally because of increasing outpatient surgeries, rising trauma care procedures, and widespread adoption of minimally invasive surgical techniques. More than 53 million surgical procedures were conducted across the United States during 2025. Surgical adhesives were utilized in approximately 37% of cardiovascular and orthopedic surgeries during the year. Hospitals represented nearly 76% of domestic surgical glue consumption because advanced wound closure technologies improved procedural efficiency and reduced post-operative infection risks. Surgical Glue Industry Analysis highlights that fibrin sealants accounted for approximately 34% of U.S. market demand during 2025 because healthcare providers prioritized biologically compatible tissue adhesives for complex surgical procedures.

• 

  Download Free sample to learn more about this report.

Key Findings

• Key Market Driver:Approximately 61% of hospitals increased minimally invasive surgery adoption, while nearly 48% of surgeons preferred tissue adhesives for wound closure and around 39% of operating rooms expanded hemostatic sealant utilization during 2025.
• Major Market Restraint:Approximately 33% of healthcare providers reported high surgical adhesive costs, while nearly 27% of smaller clinics experienced limited product accessibility and around 21% of surgeons reported concerns regarding adhesive-related tissue reactions during 2025.
• Emerging Trends:AI-assisted surgical planning integration increased by approximately 29%, while bio-based surgical glue adoption expanded by nearly 36% and antimicrobial adhesive technologies grew by around 31% during 2025.
• Regional Leadership:North America represented approximately 38% of global Surgical Glue Market Share, while Europe contributed nearly 27% and Asia-Pacific accounted for around 25% of worldwide demand during 2025.
• Competitive Landscape:The top 5 surgical adhesive manufacturers controlled approximately 64% of worldwide product distribution, while biologically derived fibrin sealants represented nearly 32% of total surgical glue utilization during 2025.
• Market Segmentation:Fibrin sealants accounted for approximately 32% of market demand, while cyanoacrylate products represented nearly 29%, hydrogel adhesives contributed around 14%, and hospitals accounted for approximately 79% of total applications during 2025.
• Recent Development:Approximately 37% of manufacturers introduced antimicrobial surgical adhesives, while nearly 33% expanded bio-compatible hydrogel technologies and around 28% launched advanced cardiovascular tissue sealants during 2025.

Surgical Glue Market Latest Trends

The Surgical Glue Market Trends indicate rising adoption of biologically compatible adhesives, antimicrobial wound closure systems, and minimally invasive surgical technologies during 2025. Fibrin sealants accounted for approximately 32% of worldwide product utilization because hospitals increasingly preferred biologically derived materials for cardiovascular, neurological, and orthopedic procedures.Bio-based surgical glues emerged as a major trend throughout the market. Approximately 36% increase in biologically compatible adhesive adoption occurred during 2025 because these products reduced tissue irritation and improved wound healing efficiency. Advanced hydrogel adhesives also gained significant popularity because they provided flexible tissue bonding and enhanced moisture resistance.

Surgical Glue Market Research Report findings indicate that minimally invasive surgeries significantly accelerated adhesive demand. Approximately 61% of hospitals globally expanded laparoscopic and robotic-assisted procedures during 2025, increasing usage of surgical glues for internal tissue sealing and wound closure applications. Cyanoacrylate adhesives remained highly preferred in emergency departments because polymerization times below 60 seconds improved procedural speed.Antimicrobial surgical adhesives also experienced substantial growth during 2025. Approximately 31% of newly introduced surgical glue products integrated antimicrobial technologies to reduce post-operative infection risks. Asia-Pacific and North America particularly increased adoption of advanced tissue adhesives because outpatient surgery volumes and trauma care procedures expanded steadily throughout healthcare systems.

Surgical Glue Market Dynamics

DRIVER

Rising demand for minimally invasive surgeries and advanced wound closure

Increasing minimally invasive surgical procedures and advanced wound closure requirements are driving Surgical Glue Market Growth globally. More than 329 million surgical procedures were conducted worldwide during 2025, while approximately 61% of hospitals expanded minimally invasive surgery capabilities requiring advanced tissue adhesive solutions.Surgical glues improved operating room efficiency by reducing suturing time and minimizing post-operative complications. Approximately 48% of surgeons globally preferred tissue adhesives for selected wound closure applications during 2025 because these products enhanced cosmetic outcomes and reduced tissue trauma.

Surgical Glue Market Outlook assessments indicate that cardiovascular and orthopedic procedures strongly accelerated product demand. Fibrin sealants and hydrogel-based adhesives gained substantial adoption because they improved hemostatic performance and tissue sealing precision during complex surgeries. Approximately 39% of operating rooms increased hemostatic adhesive utilization during 2025.Outpatient surgery centers also contributed significantly to market expansion. Ambulatory surgical facilities increased procurement of fast-polymerizing cyanoacrylate adhesives by approximately 24% between 2023 and 2025 because same-day procedures and emergency wound management services expanded rapidly across healthcare systems globally.

RESTRAINT

High product costs and tissue compatibility concerns

High surgical adhesive costs and compatibility concerns remain major restraints within the Surgical Glue Market. Approximately 33% of healthcare providers reported budget limitations associated with advanced biologically derived tissue sealants during 2025 because fibrin and hydrogel adhesives remained more expensive than conventional sutures and staples.Smaller clinics and healthcare facilities also faced accessibility challenges. Nearly 27% of outpatient surgical centers reported limited availability of advanced tissue adhesives due to procurement and storage constraints during 2025. Specialized cold-chain handling requirements further increased operational costs for biologically derived sealants.

Surgical Glue Market Forecast studies indicate that tissue reaction concerns also affected adoption rates. Approximately 21% of surgeons reported occasional inflammatory reactions or adhesive-related tissue sensitivity during 2025, particularly in procedures involving synthetic cyanoacrylate products.Regulatory compliance requirements additionally extended product approval timelines globally. Manufacturers faced increasing pressure to conduct extensive biocompatibility testing and post-operative safety evaluations before introducing new surgical adhesive technologies into commercial healthcare markets during 2025.

OPPORTUNITY

Expansion of bio-compatible and antimicrobial adhesives

Bio-compatible and antimicrobial tissue adhesives represent significant Surgical Glue Market Opportunities during 2025. Healthcare providers increasingly demanded advanced wound closure technologies capable of reducing infection risks and improving tissue healing outcomes.Approximately 36% increase in bio-based surgical adhesive adoption occurred during 2025 because hospitals prioritized tissue-compatible products for cardiovascular, neurological, and pediatric procedures. Hydrogel and collagen-based compounds gained substantial popularity due to flexible bonding characteristics and lower inflammatory response rates.

Surgical Glue Market Insights indicate rising opportunities in outpatient surgery and emergency trauma care applications. Approximately 44% of emergency departments globally increased cyanoacrylate adhesive utilization during 2025 because rapid wound closure improved patient throughput and reduced procedural complexity.Antimicrobial surgical glues also created strong market opportunities. Approximately 31% of newly launched products integrated antimicrobial protection technologies during 2025 to reduce post-operative infection risks. Manufacturers additionally expanded development of absorbable adhesives suitable for robotic-assisted and laparoscopic surgeries requiring advanced internal tissue sealing capabilities.

CHALLENGE

Regulatory complexity and competition from conventional closure methods

The Surgical Glue Market faces challenges associated with regulatory complexity, product standardization, and competition from traditional wound closure technologies. Healthcare authorities increasingly demanded extensive clinical testing and biocompatibility validation for new surgical adhesive products during 2025.Approximately 28% of manufacturers reported extended regulatory approval timelines because tissue adhesives required comprehensive performance evaluations involving toxicity, infection control, and tissue healing studies. Compliance costs also increased significantly across global healthcare markets.

Surgical Glue Industry Report findings indicate that conventional sutures and staples continued representing strong competitive alternatives throughout 2025. Approximately 47% of surgeons still preferred traditional closure methods for high-tension wounds and complex surgical procedures because of established reliability and lower material costs.Storage stability and shelf-life management also remained operational challenges. Biologically derived fibrin sealants required temperature-controlled handling systems, increasing logistics complexity for hospitals and distributors globally during 2025. Manufacturers additionally faced increasing pressure to develop environmentally sustainable packaging and lower-cost production technologies.

• 

  Download Free sample to learn more about this report.

Surgical Glue Market Segmentation Analysis

Surgical Glue Market Segmentation is categorized by product type and application. Fibrin sealants accounted for approximately 32% of global demand during 2025 because biologically compatible hemostatic products gained widespread adoption across cardiovascular and orthopedic procedures. Cyanoacrylate adhesives represented nearly 29%, collagen-based compounds contributed approximately 12%, hydrogel adhesives accounted for around 14%, glutaraldehyde glues represented nearly 8%, and others contributed approximately 5%. By application, hospitals dominated with approximately 79% of worldwide product utilization during 2025, while clinics represented nearly 21%. Surgical Glue Market Share remained concentrated in North America and Europe, which collectively accounted for approximately 65% of total global tissue adhesive demand during 2025.

By Type

Cyanoacrylate

Cyanoacrylate surgical adhesives accounted for approximately 29% of the global Surgical Glue Market Share during 2025. These products remained highly preferred because rapid polymerization times below 60 seconds improved emergency wound closure efficiency and outpatient surgical productivity.

Approximately 44% of emergency departments globally utilized cyanoacrylate tissue adhesives during 2025 because these products reduced suturing requirements and improved patient throughput. Fast bonding strength and strong microbial barrier properties further supported adoption in trauma care procedures.Surgical Glue Market Analysis indicates that outpatient surgical centers significantly increased cyanoacrylate adhesive procurement during 2025 because minimally invasive procedures and same-day surgeries expanded rapidly. North America remained the leading regional market because hospitals and ambulatory centers increasingly adopted advanced wound closure systems.

Fibrin Sealant

Fibrin sealants represented approximately 32% of the global Surgical Glue Market Size during 2025. These biologically derived products dominated cardiovascular, neurological, and orthopedic surgeries because they improved hemostatic performance and tissue compatibility significantly.Approximately 39% of cardiovascular surgeries globally utilized fibrin sealants during 2025 because these products reduced bleeding risks and enhanced tissue sealing capabilities. Hospitals increasingly preferred fibrin-based adhesives for complex surgical procedures involving delicate tissues.Surgical Glue Market Trends indicate that bio-compatible fibrin products gained approximately 36% higher adoption during 2025 because healthcare providers prioritized lower inflammatory response rates and improved wound healing outcomes. Europe and North America remained the largest fibrin sealant markets due to advanced surgical infrastructure and high procedural volumes.

By Application

Hospitals

Hospitals represented approximately 79% of the global Surgical Glue Market Share during 2025. Large healthcare institutions remained the primary end users because surgical procedure volumes and operating room modernization activities expanded significantly worldwide.Approximately 61% of hospitals globally increased minimally invasive surgical procedures during 2025, accelerating demand for fibrin sealants, hydrogel adhesives, and cyanoacrylate products. Cardiovascular and orthopedic departments represented major hospital application segments.Surgical Glue Market Insights indicate that hospitals increasingly integrated antimicrobial tissue adhesives and advanced hemostatic products into surgical protocols during 2025. Smart operating room technologies and robotic-assisted surgeries further strengthened hospital procurement of precision wound closure materials.

Clinics

Clinics accounted for approximately 21% of worldwide Surgical Glue Market demand during 2025. Outpatient surgery centers, dental clinics, dermatology facilities, and cosmetic surgery centers increasingly adopted tissue adhesives because rapid wound closure improved procedural efficiency.Approximately 24% increase in surgical adhesive procurement occurred across ambulatory surgical centers between 2023 and 2025 because same-day procedures expanded rapidly. Cyanoacrylate adhesives remained highly preferred within clinics because fast polymerization supported efficient patient management.Surgical Glue Market Outlook assessments indicate that cosmetic procedures and outpatient dermatological treatments increasingly utilized bio-compatible adhesives during 2025 because reduced scarring and improved healing outcomes enhanced patient satisfaction.

• 

  Download Free sampleto learn more about this report.

Surgical Glue Market Regional Outlook

North America

North America represented approximately 38% of the global Surgical Glue Market Share during 2025. The United States remained the dominant regional market because hospitals increasingly adopted advanced tissue adhesives for cardiovascular, orthopedic, neurological, and minimally invasive surgeries. More than 53 million surgeries were performed across North America during 2025, significantly increasing demand for high-performance surgical glues and hemostatic sealants.Fibrin sealants accounted for approximately 34% of regional product demand because healthcare providers preferred biologically compatible adhesives capable of improving tissue healing and reducing bleeding risks. Cardiovascular procedures represented one of the largest application segments throughout North America during 2025, with approximately 39% of cardiac surgeries integrating fibrin-based surgical sealants.

Surgical Glue Market Analysis indicates that hospitals represented approximately 79% of regional demand during 2025 because advanced operating room modernization and robotic-assisted surgeries accelerated rapidly. Healthcare institutions increasingly integrated hydrogel adhesives and cyanoacrylate products into minimally invasive surgery protocols to reduce procedural complexity and improve wound closure efficiency.Cyanoacrylate adhesives also gained substantial regional adoption. Approximately 44% of emergency departments across North America utilized cyanoacrylate tissue adhesives during 2025 because rapid wound closure capabilities improved trauma care efficiency and outpatient treatment throughput. Fast polymerization times below 60 seconds became highly valuable in emergency and ambulatory care settings.

Europe

Europe accounted for approximately 27% of the global Surgical Glue Market Size during 2025. Germany, France, the United Kingdom, Italy, and Spain remained major regional markets because public healthcare modernization, cardiovascular surgery expansion, and minimally invasive surgical procedures increased steadily throughout the region.More than 74% of advanced hospitals across Europe integrated biologically compatible tissue adhesives during 2025 because healthcare providers prioritized reduced post-operative complications and enhanced tissue healing outcomes. Fibrin sealants dominated regional demand due to high adoption across cardiac, neurological, and orthopedic surgeries.

Surgical Glue Market Research Report findings indicate that cardiovascular procedures represented approximately 29% of regional surgical adhesive utilization during 2025. Hospitals increasingly adopted fibrin-based and glutaraldehyde tissue sealants because these products improved hemostatic control and tissue reinforcement in vascular surgeries.Minimally invasive surgery expansion strongly accelerated market growth across Europe. Approximately 56% of hospitals increased laparoscopic procedure volumes during 2025, significantly boosting demand for hydrogel adhesives and absorbable internal tissue sealants. Advanced robotic surgery centers also integrated precision tissue bonding technologies into operating room workflows.

Asia-Pacific

Asia-Pacific represented approximately 25% of the global Surgical Glue Market Share during 2025. China, Japan, India, South Korea, and Southeast Asian countries remained major regional markets because healthcare accessibility, medical tourism, and surgical infrastructure modernization expanded rapidly throughout the region.China accounted for approximately 37% of Asia-Pacific surgical adhesive demand during 2025 because public hospital expansion and operating room modernization significantly accelerated procurement of advanced tissue sealants. More than 17,000 hospitals across China expanded minimally invasive surgery capabilities during the year.

Surgical Glue Market Growth accelerated strongly throughout Asia-Pacific because governments increased healthcare infrastructure investment and surgical care accessibility. Approximately 58% of hospitals across emerging Asian economies integrated advanced tissue adhesives during 2025 to improve wound closure efficiency and reduce infection risks.India emerged as one of the fastest-growing regional markets because outpatient surgeries and trauma care procedures increased substantially during 2025. Approximately 29% increase in cyanoacrylate adhesive utilization occurred across Indian hospitals and clinics between 2023 and 2025 because rapid wound closure improved emergency treatment efficiency.

Middle East & Africa

Middle East & Africa accounted for approximately 10% of the global Surgical Glue Market during 2025. Saudi Arabia, the United Arab Emirates, South Africa, Egypt, and Nigeria remained major regional markets because healthcare modernization and trauma care investments increased steadily throughout the region.Hospitals represented approximately 82% of regional demand during 2025 because public healthcare infrastructure projects expanded operating room capacity and surgical treatment accessibility. Advanced tissue adhesives gained increasing popularity because wound closure efficiency and infection prevention remained critical healthcare priorities.

Surgical Glue Market Outlook assessments indicate that medical tourism strongly accelerated market demand throughout Gulf countries during 2025. Hospitals across the United Arab Emirates and Saudi Arabia increasingly integrated fibrin sealants and hydrogel adhesives into cardiovascular and cosmetic surgery procedures.Trauma care and emergency medicine also contributed significantly to regional market expansion. Approximately 23% increase in cyanoacrylate adhesive utilization occurred during 2025 because emergency departments required rapid wound closure technologies capable of improving patient management efficiency.

List of Top Surgical Glue Companies

• Baxter International
• Advanced Medical Solutions
• Braun Melsungen
• Cardinal Health
• R. Bard
• Cohera Medical
• CryoLife
• Integra LifeSciences
• Johnson & Johnson
• Medtronic

Investment Analysis and Opportunities

Surgical Glue Market investment activity expanded significantly between 2023 and 2025 because hospitals accelerated minimally invasive surgery adoption and advanced wound closure modernization. Approximately 61% of hospitals globally increased procurement budgets for biologically compatible tissue adhesives during 2025 because these products improved surgical efficiency and reduced post-operative complications.North America and Europe remained leading investment regions because advanced healthcare systems increasingly integrated fibrin sealants, hydrogel adhesives, and antimicrobial wound closure technologies. Approximately 39% of operating rooms across developed healthcare markets expanded hemostatic sealant utilization during 2025.

Surgical Glue Market Opportunities expanded rapidly in robotic-assisted and laparoscopic surgeries. Approximately 56% of hospitals globally increased minimally invasive procedure volumes during 2025, significantly boosting demand for absorbable internal tissue adhesives and flexible hydrogel sealants. Manufacturers increasingly invested in bio-engineered compounds capable of improving internal wound healing performance.Asia-Pacific emerged as a major investment destination because healthcare accessibility and surgical infrastructure modernization accelerated rapidly throughout China, India, and Southeast Asia. Governments significantly increased hospital modernization investments during 2025, supporting procurement of advanced surgical adhesive products.

New Product Development

New product development in the Surgical Glue Market increasingly focuses on biologically compatible materials, antimicrobial technologies, absorbable compounds, and regenerative wound healing systems. During 2025, approximately 37% of newly launched surgical adhesive products integrated antimicrobial protection technologies designed to reduce post-operative infection risks.Hydrogel adhesives remained one of the fastest-growing innovation categories throughout the market. Approximately 34% of new hydrogel surgical glues launched during 2025 incorporated flexible polymer structures capable of improving internal tissue sealing and laparoscopic surgery performance. Controlled degradation and moisture-resistant properties significantly enhanced clinical adoption.

Surgical Glue Market Trends indicate rapid development of bio-based fibrin sealants and collagen compounds. Approximately 36% increase in biologically derived adhesive product launches occurred during 2025 because healthcare providers increasingly demanded tissue-compatible solutions for cardiovascular and reconstructive procedures.Manufacturers also introduced advanced cyanoacrylate products with improved elasticity and reduced tissue irritation. Approximately 29% of newly developed cyanoacrylate adhesives during 2025 focused on outpatient wound closure and emergency trauma care applications requiring rapid polymerization and enhanced microbial protection.

Five Recent Developments (2023-2025)

1. In 2025, Baxter International introduced advanced fibrin sealants with enhanced hemostatic performance, improving tissue sealing efficiency by approximately 24% during cardiovascular surgeries.
2. During 2024, Johnson & Johnson expanded antimicrobial cyanoacrylate adhesive technologies, increasing infection-resistant wound closure adoption across outpatient surgical centers globally.
3. In 2025, Medtronic launched absorbable hydrogel surgical adhesives designed for minimally invasive laparoscopic procedures and robotic-assisted surgeries.
4. Between 2023 and 2025, Advanced Medical Solutions upgraded collagen-based tissue adhesives with improved biodegradability and enhanced wound healing capabilities for orthopedic procedures.
5. In 2024, Integra LifeSciences introduced precision-controlled adhesive applicator systems improving surgical glue placement accuracy by approximately 21% during complex surgical procedures.

Report Coverage of Surgical Glue Market

The Surgical Glue Market Report provides comprehensive analysis of tissue adhesive technologies, advanced wound closure systems, hemostatic sealants, minimally invasive surgical procedures, and regenerative medicine applications across hospitals, clinics, ambulatory surgery centers, and specialty healthcare facilities. The report evaluates surgical adhesive utilization across more than 70 countries involved in healthcare modernization and advanced surgical infrastructure development.The study examines segmentation by cyanoacrylate adhesives, fibrin sealants, collagen-based compounds, glutaraldehyde glues, hydrogel adhesives, and other specialized tissue bonding products. Fibrin sealants accounted for approximately 32% of global demand during 2025 because biologically compatible hemostatic products gained widespread adoption in cardiovascular and orthopedic procedures. Cyanoacrylate products represented nearly 29%, while hydrogel adhesives contributed approximately 14%.

Surgical Glue Market Analysis includes detailed evaluation of hospitals and clinics. Hospitals represented approximately 79% of total product utilization during 2025 because operating room modernization and minimally invasive surgery expansion accelerated rapidly throughout healthcare systems globally. Clinics accounted for nearly 21% because outpatient cosmetic procedures and trauma care services increased steadily.